Previous 10 | Next 10 |
Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. If you're interested in this serv...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:10 a.m. MST (8:10 a.m. PST, 11:10 a.m. EST) on Wednesday, November 14, at the ...
HENDERSON, NV / ACCESSWIRE / November 7, 2018 / Midterm elections are expected to result in a split Congress, which should increase predictability for the biotech industry, and prevent, what some see as disruptive, government dictated pricing, less likely than if there is a Congress controll...
More news on: Datawatch Corporation, JinkoSolar Holding Co., Ltd., Yulong Eco-Materials, , Stocks on the move, Read more ...
In August, I concluded that a small speculative position might be warranted in shares of Puma Biotechnology ( PBYI ) . I was attracted to the fall in the shares, in combination with the fact that the company had an approved product, and the pick-up in sales for that drug seemed to be goin...
More news on: Pacific Biosciences of California, Emerge Energy Services LP, VivoPower International PLC, Stocks on the move, , Read more ...
Puma Biotechnology (NYSE: PBYI ) -39% on Q3 earnings . More news on: Puma Biotechnology, Inc., Universal Display Corporation, Weight Watchers International, Inc., Stocks on the move, , Top stock market news, Read more ...
Sell-side analysts weigh in Puma Biotechnology (NYSE: PBYI ) after it posted Q3 results yesterday that featured less-than-expected sequential growth for top seller Nerlynx (neratinib). More news on: Puma Biotechnology, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov...
Puma Biotechnology, Inc. (PBYI) Q3 2018 Earnings Call November 01, 2018 4:30 pm ET Executives Mariann Ohanesian - Puma Biotechnology, Inc. Alan H. Auerbach - Puma Biotechnology, Inc. Steven Lo - Puma Biotechnology, Inc. Charles R. Eyler - Puma Biotechnology, Inc. Analysts ...
News, Short Squeeze, Breakout and More Instantly...
Puma Biotechnology Inc Company Name:
PBYI Stock Symbol:
NASDAQ Market:
Puma Biotechnology Inc Website:
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, August 1, 2024, following the release of its second quarter 2024 financial results. The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor receptor-mutated (EGFR-mutated) non-small cell lung cancer (NCT04085315) at the 2024 American Soc...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the treatment of patients with endocrine and CDK4/6 inhibitor (CDK 4/6i) resistant, h...